Organometallics
Article
(roofing doublets). 13C{1H} NMR (100 MHz, CD3CN): δ 176.8
(NCH), 129−137 (Ar-C and P-Ar-C), 120.8 (NCMe), 77.4 (N−
C(Ph)H), 27.4 (CH2), and 1.0 (NCCH3) ppm. Anal. Calcd for
[FeC45H42P2N4][BF4]2: C, 58.1; H, 4.6; N, 6.0. Found: C, 55.01; H,
4.26; N, 5.35.** MS (ESI, m/z+): 337 [C41H36P2N2]2+ (loss of two
MeCN), and 316.6 [C39H33P2N]2+ (loss of three MeCN).
2JPP = 138.4 Hz), and 43.31 (d, 2JPP = 138.4 Hz) ppm. 13C{1H} NMR
(125 MHz, CD3CN): δ 126−137 (Ph-C), 122.0 (NCMe), 62.50 (N-
C(Me)H), 52.78 (N-CH2), 50.50 (P-C(Ph)H), 17.11 (−CH3), and
1.31 (NC-CH3) ppm. Anal. Calcd for [FeC46H46P2N4][BF4]2 (extra
MeCN in solution, verified by NMR): C, 58.39; H, 5.00; N, 7.09.
Found: C, 48.80; H, 4.58; N, 7.85.** MS (ESI, m/z+): 656.2
[FeC40H37P2N][Li]+ (loss of three MeCN).
6e: R1 = CH2Ph, R2 = H. From 4e (0.086 g, 0.15 mmol), Yield: 136
mg, 96%. 1H NMR (400 MHz, CD3CN): δ 8.33 (d, 1H, NCH, 4JHH
= 5.4 Hz), 7.92 (t, 2H, Ph−CH, J = 8.0 Hz), 7.2−7.8 (m, 25H, Ph−
CH), 6.95 (d, 2H, Ph−CH, J = 4.8 Hz), 4.00 (m, 1H, N−CH), 3.27
(CH2-Ph, 1H, overlapping with 3.20 - determined indirectly from
1H−1H COSY), 3.20 (CH2-PPh2, 1H, overlapping with 3.27,
determined indirectly from 1H−1H COSY), 3.08 (dd, 1H, CH2-
7d: R1 = Ph, R2 = H. From 5d (0.075 g, 0.13 mmol), Yield: 114 mg,
1
99%. H NMR (600 MHz, CD3CN): δ 7.25−7.88 (m, 28H, Ph-CH),
3
6.76 (s, 1H, Ph-CH), 3.63 (t, 1H, P-CH2, JHH = 13.8 Hz), 3.46 (m,
1H, N-C(Ph)H), 3.15 (m, 1H, N-CH2), 2.94 (t, 1H, N-CH2), 2.77 (m,
1
1H, P-CH2), 2.00 (NH, determined indirectly using H−1H-COSY),
and 1.98 (s, NC-CH3/NC-CD3) ppm. 31P{1H} NMR (242 MHz,
CD3CN): δ 49.07 (d, 2JPP = 139.1 Hz), and 41.22 (d, 2JPP = 139.1 Hz)
ppm. 13C{1H} NMR (150 MHz, CD3CN): δ 126−133 (Ph-C), 120.4
(NCMe), 67.24 (N-C(Ph)H), 53.84 (N-CH2), 32.92 (P-CH2), and
0.68 (NC-CH3) ppm. Anal. Calcd for [FeC45H44P2N4][BF4]2: C,
57.98; H, 4.76; N, 6.01. Found: C, 54.66; H, 4.92; N, 6.04.** MS
(DART, m/z+): 380.2 [FeC45H44P2N4]2+.
3
2
PPh2, JHH and JHH = 7.7 and 14.0 Hz), 2.80 (m, 1H, CH2-Ph), and
2.00 (s, NC−CH3/NC-CD3) ppm. 31P{1H} NMR (161 MHz,
2
2
CD3CN): δ 54.7 (d, JPP = 151 Hz), and 51.7 (d, JPP = 151 Hz)
ppm (roofing doublets). 13C{1H} NMR (100 MHz, CD3CN): δ 176.1
(d, NCH, J = 5.4 Hz), 127−137 (Ar-C and P-Ar-C), 118.6
(NCMe), 76.1 (N-CH), 39.3 (CH2-PPh2), 27.8 (CH2-Ph), and 0.5
(NC−CH3) ppm. Anal. Calcd for [FeC46H44P2N4][BF4]2: C, 58.5; H,
4.7; N, 5.9. Found: C, 56.39; H, 5.0; N, 5.49.** MS (ESI, m/z+): 606.2
[FeC36H35P2N]Li+ (loss of three MeCN).
7e: R1 = CH2Ph, R2 = H. From 5e (0.025 g, 0.042 mmol), Yield: 38
1
mg, 95%. H NMR (600 MHz, CD3CN): δ 7.06−7.83 (m, 29H, Ph-
CH), 3.90 (m, 1H, N-CH2), 3.73 (m, 1H, P-CH2), 3.13 (m, 1H, CH2-
Ph), 3.02 (m, 1H, N-CH2), 2.71 (m, 1H, N-C(Bn)H), 2.60 (m, 1H, P-
CH2), 2.23 (m, 1H, Ph-CH2), 1.98 (s, NC-CH3/NC-CD3), 1.97 (NH,
determined indirectly using 1H−1H-COSY) ppm. 31P{1H} NMR (242
6f: R1 = iPr, R2 = H. From 4f (0.099 g, 0.18 mmol), Yield: 152 mg,
1
94%. H NMR (400 MHz, CD3CN): δ 8.58 (s, 1H, NCH), 7.96
(m, 2H, Ph−CH), 7.4−7.8 (m, 18H, Ph−CH), 7.30 (m, 4H, Ph-CH),
2
2
3.74 (dm, 1H, N-CH), 3.32 (m, 1H, CH2-PPh2), 2.84 (dd, 1H, CH2-
MHz, CD3CN): δ 48.82 (d, JPP = 139.9 Hz), and 41.38 (d, JPP
=
3
PPh2, JHH and 2JHH = 7.8 and 14.7 Hz), 1.94 (s, NC-CH3/NC-CD3),
139.9 Hz) ppm. 13C{1H} NMR (150 MHz, CD3CN): δ 126−133 (Ph-
C), 123.0 (NCMe), 63.78 (N-C(Bn)H), 52.72 (N-CH2), 37.87 (P-
CH2), 30.1 (Ph-CH2), and 1.06 (NC-CH3) ppm. Anal. Calcd for
[FeC46H46P2N4][BF4]2: C, 58.39; H, 4.90; N, 5.92. Found: C, 49.34;
H, 4.78; N, 5.56.** MS (ESI, m/z+): 656.2 [FeC40H37P2N][Li]+ (loss
of three MeCN).
1.25 (m, 1H, iPr-CH), 0.87 (d, 3H, iPr-CH3, 3JHH = 6.2 Hz), and 0.00
3
(d, 3H, iPr-CH3, JH2H = 6.5 Hz) ppm. 31P{1H} NMR (161 MHz,
2
CD3CN): δ 53.8 (d, JPP = 151.6 Hz), and 57.3 (d, JPP = 151.6 Hz)
ppm. 13C{1H} NMR (100 MHz, CD3CN): δ 177.9 (NCH), 129−
138 (Ar-C and P-Ar-C), 121.0 (NCMe), 87.5 (N-CH), 30.0 (iPr-CH),
24.4 (CH2-PPh2), 19.2 (iPr-CH3), 18.1 (iPr-CH3), and 1.2 (NC-CH3)
ppm. Anal. Calcd for [FeC42H44P2N4][BF4]2: C, 58.9; H, 4.7; N, 5.9.
Found: C, 47.08; H, 4.44; N, 4.87.** MS (ESI, m/z+): 606.2
[FeC36H35P2N]Li+ (loss of three MeCN).
7f: R1 = iPr, R2 = H. From 5f (0.063 g, 0.12 mmol), Yield: 88 mg,
1
83%. H NMR (400 MHz, CD3CN): δ 7.22−7.86 (m, 24H, Ph-CH),
4.12 (m, 1H, N-CH(iPr)), 3.66 (m, 1H, N-CH2), 3.44 (m, 1H, P-
CH2), 2.84 (m, 1H, N-CH2), 2.13 (P-CH2, determined indirectly from
13C−1H HSQC), 1.99 (s, NC-CH3/NC-CD3), 1.43 (br s, 1H, NH),
1.19 (m, 1H, iPr-CH), and 0.77 (br m, 6H, iPr-CH3) ppm. 31P{1H}
6g: R1 = R2 = Ph. From 4g (0.038 g, 0.058 mmol), Yield: 55 mg,
1
96%. H NMR (400 MHz, CD3CN): δ 8.15 (s, 1H, NCH), 6.95−
7.80 (m, 34H, Ph−CH), 5.17 (dd, 1H, N-CH(Ph), 3JHH = 13.0 and 7.3
2
NMR (161 MHz, CD3CN): δ 49.55 (d, JPP = 139.8 Hz), and 41.25
3
2
(d, JPP = 139.8 Hz) ppm. 13C{1H} NMR (100 MHz, CD3CN): δ
Hz), 4.88 (dd, 1H, CH(Ph)-PPh2, JHH = 7.7 and 13.0 Hz), and 2.00
(s, 9H, NC−CH3) ppm. 31P{1H} NMR (161 MHz, CD3CN): δ 69.79
128−135 (Ar-C and P-Ar-C), 121.90 (NCMe), 62.01 (N-CH(iPr))
51.69 (N-CH2), 23.95 (P-CH2), 20.64 (iPr-CH), 12.55 (iPr-CH3), and
0.83 (NC-CH3) ppm. Anal. Calcd for [FeC42H46P2N4][BF4]2: C,
56.16; H, 5.16; N, 6.23. Found: C, 47.42; H, 4.38; N, 6.23.** MS (ESI,
m/z+): 362.2 [FeC42H46P2N4]2+and 608.2 [FeC36H37P2N]Li+.
Synthesis of Fe(P-N-P′)(CO)Br2 (8). In a nitrogen-filled glovebox, 4a
(0.05 g, 0.1 mmol) was added to a solution of FeBr2 (0.22 g, 0.1
mmol) in 5 mL of THF and the mixture was stirred at room
temperature for 45 min. The solution was then frozen using liquid
nitrogen, and the gases were removed under reduced pressure. A
carbon monoxide headspace was introduced, and the solution was
warmed to room temperature and stirred for an additional 2 h. The
solvent was removed under reduced pressure, and the crude product
was washed with ether and hexanes. The residue was dissolved in a
minimal amount of DCM, and the product was precipitated out with
cold pentane. The powder was filtered and washed with cold pentane
and then dried under reduced pressure to yield pure Fe-P-N-P′
product. Yield: 63 mg, 85%.
2
2
(d, JPP = 148.5 Hz), and 53.34 (d, JPP = 148.5 Hz). 13C{1H} NMR
(100 MHz, CD3CN): δ 177.9 (NCH), 127−137 (Ar-C and P-Ar-
C), 117.6 (NCMe), 81.7 (N−CH(Ph)), 46.6 (CH(Ph)-PPh2), and
0.34 (NC-CH3) ppm. Anal. Calcd for [FeC51H46P2N4][BF4]2: C,
60.87; H, 4.61; N, 5.57. Found: C, 59.57; H, 4.67; N, 5.07. MS (ESI,
m/z+): 415.2 [FeC51H46P2N4]+2.
7a: R1 = R2 = H. From 5a (0.103 g, 0.20 mmol), Yield: 167 mg,
98%. 1H NMR (400 MHz, CD3CN): δ 7.90 (m, 2H, Ph-CH), 7.80
(m, 2H, Ph-CH), 7.45−7.75 (m, 17H, Ph-CH), 7.37 (t, 1H, Ph-CH, J
= 8.3 Hz), 7.28 (m, 2H, Ph-CH), 3.54 (dd, 1H, Ph-CH2-NH, 3JHH and
4JHH = 13.0 and 3.8 Hz), 3.44 (t, 1H, CH2-PPh2, 3JHH = 14.6 Hz), 3.19
(m, 1H, Ph-CH2-NH), 3.10 (m, 1H, NH-CH2-CH2), 2.49 (m, 1H,
CH2-PPh2), 2.38 (m, 1H, NH), 2.32 (m, 1H, NH-CH2-CH2), and 1.99
(s, NC-CH3/NC-CD3) ppm. 31P{1H} NMR (161 MHz, CD3CN): δ
2
2
58.69 (d, JPP = 141.9 Hz), and 43.74 (d, JPP = 141.9 Hz) ppm.
13C{1H} NMR (100 MHz, CD3CN): δ 127−141 (Ar-C and P-Ar-C),
119.1 (NCMe), 57.3 (Ph-CH2-NH), 53.8 (HN-CH2-CH2), 24.2 (CH2-
PPh2), and 0.49 (NC-CH3) ppm. Anal. Calcd for [FeC39H40P2N4]-
[BF4]2: C, 54.7; H, 4.7; N, 6.5. Found: C, 53.22; H, 4.96; N, 6.27.**
MS (ESI, m/z+): 339.3 [FeC39H40P2N4]2+, 318.1 (loss of MeCN),
300.1 (loss of two MeCN), and 279.6 (loss of three MeCN).
7c: R1 = Me, R2 = Ph. From 5c (0.030 g, 0.050 mmol), Yield: 47
1H NMR (600 MHz, CD2Cl2): δ 8.36 (s, 1H, NCH), 8.25 (dd,
2H, Ph-CH, J = 7.7 and 10.0 Hz), 8.08 (m, 2H, Ph-CH), 8.03 (m, 2H,
Ph-CH), 7.31−7.65 (m, 17H, Ph-CH), 7.26 (t, 1H, Ph-CH, J = 8.1
Hz), 4.00 (m, 1H, N-CH2), 3.43 (m, 1H, N-CH2), 3.02 (m, 1H, P-
CH2), and 2.55 (m, 1H, P-CH2) ppm. 31P{1H} NMR (242 MHz,
1
2
2
mg, 99%. H NMR (500 MHz, CD3CN): δ 7.00−7.68 (m, 29H, Ph-
CD2Cl2): δ 44.01 (d, JPP = 216.9 Hz), 39.55 (d, JPP = 216.9 Hz)
ppm. 13C{1H} NMR (150 MHz, CD2Cl2): δ 173.7 (NCH),126−
137 (Ph-C), 71.5 (N-CH2), and 24.1 (P-CH2) ppm. Anal. Calcd for
[C34H29NP2OFeBr2]: C, 54.8; H, 3.92; N, 1.88. Found: C, 54.93; H,
4.19; N, 2.74. MS (TOF-ESI, m/z+): 636.0 [C33H29NP2FeBr]+ (loss of
CO, Br). IR: ν(CO) 1960.6 cm−1.
CH), 3.99 (dd, 1H, P-C(Ph)H, J = 7.7 and 12.2 Hz), 3.82 (dd, 1H, N-
4
3
CH2, JHH and JHH = 5.1 and 13.1 Hz), 3.04 (m, 1H, N-CH2), 2.88
(m, 1H, N-C(Me)H), 1.99 (s, NC−CH3/NC-CD3), 1.92 (NH,
1
determined indirectly using H−1H-COSY), and 1.17 (d, 3H, CH3,
3JHH = 5.8 Hz) ppm. 31P{1H} NMR (202 MHz, CD3CN): δ 74.30 (d,
L
dx.doi.org/10.1021/om5008083 | Organometallics XXXX, XXX, XXX−XXX